Psychotherapists’ Ethical Dilemmas Regarding Online and Face-to-Face Psychotherapy During the COVID-19 Pandemic: Survey Study.

Psychotherapists’ Ethical Dilemmas Regarding Online and Face-to-Face Psychotherapy During the COVID-19 Pandemic: Survey Study.

Publication date: Sep 17, 2025

During the COVID-19 pandemic, mental health professionals were forced to find an appropriate way of working with patients that would ensure the continuity of therapy while considering the restrictions aimed at counteracting the spread of the virus. Online therapy has become an increasingly popular and common form of psychotherapeutic work. Emerging scientific studies have confirmed the positive effects of remote psychotherapeutic work. Nevertheless, modifying traditional and well-known forms of therapy or introducing completely new forms of remote therapy have been associated with several ethical concerns and challenges for psychotherapists. Due to the COVID-19 pandemic and the emerging epidemiological restrictions and recommendations, as well as new recommendations from psychotherapeutic associations, this study aimed to investigate the following: (1) Have psychotherapists experienced ethical dilemmas related to working online and face-to-face during the COVID-19 pandemic? (2) Was the occurrence of these dilemmas related to the therapists’ personal characteristics, such as age, sex, professional experience, or therapeutic approach? (3) What specific ethical dilemmas do psychotherapists point to in conducting online and face-to-face therapy during the COVID-19 pandemic? We conducted an international study with 177 psychotherapists from 4 European countries (Sweden, Poland, Germany, and Portugal) using a web-based survey. The psychotherapeutic approaches represented in the sample were cognitive-behavioral, integrative, psychodynamic-psychoanalytic, systemic, existential and gestalt, and Ericksonian therapy, among others. An interview comprising closed and open questions was used to collect data on psychotherapists’ personal characteristics, professional functioning, and ethical dilemmas encountered during online and face-to-face therapy. Ethical dilemmas related to online therapy were reported by 58. 7% (104/177) of therapists, while dilemmas related to face-to-face therapy were reported by 61% (108/177). The study showed that these dilemmas were independent of the personal and professional characteristics of therapists. Dilemmas related to online therapy were concern about online therapy, the issue of privacy and confidentiality of sessions, the effectiveness of online therapy, the issue of limitations that may hinder clinical work, and concerns related to the broader systemic and institutional context. In contrast, for the face-to-face form, ethical dilemmas mainly concerned health and safety, limitations in communication and quality of relationships due to wearing masks, and technical and logistical limitations. The issues considered here have not lost their relevance, because despite the lifting of restrictions related to the pandemic, some of the described dilemmas are similar to those related to coping with the risk and transmission of infection during face-to-face meetings. Moreover, the spread of online therapy means that the related ethical dilemmas are still relevant. The results indicate the direction of further consideration, the outcome of which should be specific ethical and legal guidelines that consider the concerns and dilemmas reported.

Open Access PDF

Concepts Keywords
Conducting Adult
Germany COVID-19
Pandemic epidemiological restrictions
Sweden Ethical Dilemmas
Therapists Female
Humans
international study
Male
Middle Aged
Pandemics
professional ethics
Psychotherapists
Psychotherapy
remote therapy
SARS-CoV-2
Surveys and Questionnaires
Telemedicine
traditional therapy

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease MESH privacy
disease IDO quality
disease MESH infection
drug DRUGBANK Coenzyme M
disease MESH emergencies
disease IDO process
disease MESH uncertainty
disease MESH home environment
disease IDO intervention
disease MESH anxiety
disease IDO country
drug DRUGBANK C31G
disease MESH communication barriers
disease MESH autoimmune diseases
disease MESH facial expression
disease MESH misdiagnosis
disease MESH coronavirus infection
disease MESH complications
drug DRUGBANK Isoxaflutole
disease IDO algorithm
pathway REACTOME Translation
disease MESH Feminization
drug DRUGBANK MK-212
disease MESH panic disorder
disease MESH agoraphobia
pathway KEGG Coronavirus disease
disease MESH depression
drug DRUGBANK Trestolone
disease MESH ADHD
disease MESH schizophrenia
drug DRUGBANK Activated charcoal
pathway REACTOME Reproduction

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *